SCHEMBL13896394

SCHEMBL13896394

O=C(NC1CCCC1)N[C@H]1CCCCC/C=C\[C@@H]2C[C@H]2NC(=O)[C@@H]2C[C@@H](OC(=O)N3CCc4ccccc4C3)CN2C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.40
▸ ALDH1A1 P00352 4/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ EPHX1 P07099 1/20 0.36
▸ KEAP1 Q14145 1/20 0.33
▸ DPP8 Q6V1X1 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ ADRB3 P13945 1/20 0.31
▸ ADRA2B P18089 1/20 0.31
▸ ADRA2C P18825 1/20 0.31
▸ FAP Q12884 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8278219 0.93 POLB (0.33) POLBALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL8294160 0.89 DRD2 (0.35) POLBALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL8295392 0.88 ALDH1A1 (0.33) POLBALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL8278885 0.87 ADRB3 (0.33) POLBALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL3970669 0.86 ADRB3 (0.43) POLBALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL3970663 0.86 ADRB3 (0.43) POLBALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL3970666 0.86 ADRB3 (0.43) POLBALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL8278254 0.85 ADRB3 (0.39) POLBALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL13886148 0.84 REN (0.33) ADRB3ADRA2BADRA2C
SCHEMBL8278256 0.84 REN (0.33) ADRB3ADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1680137-B1 Macrocyclic carboxylic acid and acylsulfonamide compound as inhibitor of HCV replication HOFFMANN LA ROCHE (CH) 2012-11-21 — — EP disclosed
Send feedback